Key result
iPSC-derived pericyte-like cells increase bioartificial cardiac tissue stiffness and induce a fibrosis-like phenotype versus fibroblasts.
Why the study?
The pathogenesis of myocardial interstitial fibrosis is difficult to study in humans, and the contribution of perivascular cells such as pericytes remains poorly understood.
hPSC-derived pericyte-like cells can be used in bioartificial cardiac tissue to model myocardial interstitial fibrosis and study vascularization and tissue remodeling in vitro.
Supports pericyte-like cells for in vitro fibrosis modeling; leaves open translation to clinical cardiac tissue engineering.
Myocardial interstitial fibrosis (MIF) is characterized by excessive extracellular matrix (ECM) deposition, increased myocardial stiffness, functional weakening, and compensatory cardiomyocyte (CM) hypertrophy. Fibroblasts (Fbs) are considered the principal source of ECM, but the contribution of perivascular cells, including pericytes (PCs), has gained attention, since MIF develops primarily around small vessels. The pathogenesis of MIF is difficult to study in humans because of the pleiotropy of mutually influencing pathomechanisms, unpredictable side effects, and the lack of available patient samples. Human pluripotent stem cells (hPSCs) offer the unique opportunity for the de novo formation of bioartificial cardiac tissue (BCT) using a variety of different cardiovascular cell types to model aspects of MIF pathogenesis in vitro. Here, we have optimized a protocol for the derivation of hPSC-derived PC-like cells (iPSC-PCs) and present a BCT in vitro model of MIF that shows their central influence on interstitial collagen deposition and myocardial tissue stiffening. This model was used to study the interplay of different cell types-i.e., hPSC-derived CMs, endothelial cells (ECs), and iPSC-PCs or primary Fbs, respectively. While iPSC-PCs improved the sarcomere structure and supported vascularization in a PC-like fashion, the functional and histological parameters of BCTs revealed EC- and PC-mediated effects on fibrosis-related cardiac tissue remodeling.
No takes yet. Share an insight, caveat, or question.
Szepes et al. (2020) studied Myocardial interstitial fibrosis (in vitro model). iPSC-derived pericyte-like cells (iPSC-PCs) vs. Fibroblasts (Fbs) was evaluated on Tissue stiffness (elastic modulus) and active contraction force. Incorporation of iPSC-derived pericyte-like cells into bioartificial cardiac tissues significantly increased tissue stiffness and induced a fibrosis-like phenotype compared to tissues with fibroblasts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: